Fidelity Growth Partners, the venture capital and private equity arm of Fidelity Worldwide Investment, says it has agreed to invest RMB62.5 million (US$10 million) in Beijing-based ophthalmology products firm Eye Bright Medical Technology Co., Ltd., according to Chinese media reports. Two entities under Fidelity Growth Partners, Fidelity Growth Partners Asia and Fidelity Biosciences, will make […]
Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.
Visit the original source and full text: China Money Network
Any news and links syndicated from other sources are copyright those respective websites and/or publications. We post brief synopsis and links per what the respective websites' RSS feeds provide.